Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

New regeNer8 virtual centre aims to advance regenerative medicine in the North of England

CELS : 25 October, 2007  (New Product)
A virtual centre has been launched that aims to bring together the work of the North of England's top scientists to advance regenerative therapies.
The N8 Centre for Translational Regenerative Medicine, regeNer8, will be the focus of collaboration between industry, clinicians and academics at the north's eight most research-intensive universities, known as the N8.

The N8 has identified regenerative medicine as one of five key areas that would benefit from virtual and physical centres of industrially focused translational research. Currently an embryonic part of the healthcare technology sector, it has been recognised as offering major opportunities for global economic growth over the next two decades.

Safety in regenerative medicine has been set as the core focus for regeNer8 following consultations with the healthcare industry, which included representatives from the bioprocessing, pharmaceuticals, biomaterials and medical devices sectors.

Under the leadership of Leeds University's deputy vice-chancellor, Professor John Fisher, scientists will discuss the repair, replacement and regeneration of soft through to hard tissues, work on which has already established them a strong reputation.

Professor Fisher commented: 'regeNer8 builds upon the extensive research activities of the Northern Universities (currently, over £100 million). It focuses on partnerships with industry and clinicians to translate basic research into novel regenerative products and therapies, which will provide economic and societal benefits to the north of England.'

RegeNer8 is part of a £6m project funded by the Northern Way, the consortium of the three Northern development agencies.

Other centres are to be set up to progress work in the fields of energy, sustainable water use, ageing and related health matters and molecular engineering.

The initiative is further bolstered by a partnership between the Leeds-based BITECIC (Biomaterials and Tissue Engineering Centre of Industrial Collaboration) and Cels (the organisation growing the healthcare sector in the North East). Together, they are providing regeNer8 with business and marketing support to translate its world-class expertise into new regenerative medicine products and therapies. Its aim is to create new commercial opportunities in the healthcare industry by gaining a competitive advantage worldwide.

The N8 partnership, launched in March and directed by Sheffield based Prof David Secher, consists of the universities of Durham, Lancaster, Leeds, Liverpool, Manchester, Newcastle, Sheffield and York.

Prof Secher said: 'The combination of the global research quality that exists across the North, with the close links to relevant industries, promises to make the N8 Research Centres powerful drivers, both for internationally competitive research and for economic development.'

regeNer8 was established during the first round of Northern Way funding and the Centre is currently bidding for the next round, worth up to £2m.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo